LIVN Q4 2021 Earnings — LivaNova PLC Revenue & Financial Results | Market Cap Arena

LIVNLivaNova PLC

$3B

Q4 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$270M+0.2% YoY

Gross Profit

$198M73.1% margin

Operating Income

$21M7.6% margin

Net Income

-$9M-3.2% margin

EPS (Diluted)

$-0.10

QoQ Revenue Growth

+6.7%

Cash Flow

Operating Cash Flow

$33M

Free Cash Flow

$26M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$2.2B

Total Liabilities

$906M

Stockholders' Equity

$1.3B

Cash & Equivalents

$208M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$270M	$270M	+0.2%
Gross Profit	$198M	$151M	+30.7%
Operating Income	$21M	-$252M	+108.2%
Net Income	-$9M	-$284M	+97.0%

Revenue Segments

Neuromodulation Segment

$122M100%

Geographic Segments

UNITED STATES

$150M55%

Locations Excluding The United States And Europe

$71M26%

Europe

$49M18%